ARIF HUSSAIN: Open Payments
NPI 1548554249 · LAWRENCEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 20 payments from 6 companies in 2025. Trend: 2023 $34 · 2024 $523 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $303 |
| ABBVIE INC. | 14 | $227 |
| Alnylam Pharmaceuticals Inc. | 1 | $150 |
| PFIZER INC. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: FARXIGA, QULIPTA, AMVUTTRA, UBRELVY, NURTEC ODT, XIFAXAN, ZEPBOUND.
Industry payments across NJ — which companies pay providers there.
